Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Proc Jpn Acad Ser B Phys Biol Sci ; 86(4): 391-409, 2010.
Article in English | MEDLINE | ID: mdl-20431263

ABSTRACT

We have demonstrated that in rats activities of various enzymes related to gluconeogenesis and amino acid metabolism show circadian rhythms. Based on these results, we have explored the molecular mechanisms underlying circadian oscillation and phase response to light of the master clock located in the dorsomedial subdivision of the suprachiasmatic nucleus (SCN) and found various proteins closely related to phase response such as BIT/SHPS-1 and those of circadian oscillation, some of which are involved in protein-tyrosine phosphorylation.On the other hand, we have presented several lines of evidence that the ventrolateral subdivision of the SCN includes not only the control center of energy supply to the brain, but also that of homeostasis such as blood glucose, blood pressure, water balance, and body temperature. We have also shown that besides these functions, the latter subdivision is involved in the regulations of hormone secretions such as insulin, glucagon, corticosterone and vasopressin. It has been also shown by electrophysiological means that light exposure to rat eye enhances sympathetic nerve activity, whereas it depresses parasympathetic nerve activity. Thus, environmental light is implicated not only in the phase-shift through the retinohypthalamic tract (RHT), but also control of autonomic nerve activities through the RHT, It is also discussed in this review how the two divisions are interconnected and how environmental light is involved in this interconnection.


Subject(s)
Circadian Rhythm/physiology , Homeostasis/physiology , Suprachiasmatic Nucleus/physiology , Animals , Autonomic Nervous System/physiology , Autonomic Nervous System/radiation effects , Circadian Rhythm/drug effects , Circadian Rhythm/genetics , Eating/physiology , Eating/radiation effects , Homeostasis/radiation effects , Humans , Light , Suprachiasmatic Nucleus/metabolism , Suprachiasmatic Nucleus/radiation effects
2.
Eur J Neurosci ; 21(3): 733-40, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15733091

ABSTRACT

We reported recently that angiotensin-converting enzyme (ACE) significantly degraded amyloid beta-peptide (A beta) to inhibit aggregation and cytotoxicity of A beta in PC12h cells in vitro. On the other hand, others reported that ACE had two domains with highly homologous active centres, the N-domain and C-domain, but that they differed in their characteristics such as optimum chloride ion concentration, inhibition kinetics for various ACE inhibitors and rate of hydrolysis for many substrates. The aim of this study was to determine the specific ACE domain primarily responsible for degradation of A beta. For this purpose, a series of ACE recombinant proteins, each containing only one intact domain, was constructed and expressed in COS7. Our results showed that all ACE recombinant proteins obtained were enzymatically active in terms of angiotensin I cleavage. However, inhibition of A beta aggregation and cytotoxicity of the N-domain were higher than those of the C-domain. Reverse-phase high-performance liquid chromatography analyses confirmed that the N domain degraded A beta. Our results indicate that the N domain of ACE is primarily responsible for the degradation of A beta.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Peptide Fragments/metabolism , Peptidyl-Dipeptidase A/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Binding Sites/drug effects , COS Cells , Chlorocebus aethiops , Humans , PC12 Cells , Peptide Fragments/pharmacology , Peptidyl-Dipeptidase A/pharmacology , Rats
3.
J Neurosci Res ; 75(5): 678-87, 2004 Mar 01.
Article in English | MEDLINE | ID: mdl-14991843

ABSTRACT

Distinctive expression of midkine (MK) was observed during the repair period of fetal brain neuroepithelium. MK is a heparin-binding growth factor that occurs as a product of a retinoic acid-inducible gene, and has a molecular mass of 13 kDa. MK expression was examined immunohistochemically and by immunoelectron microscopy during a period of repair in developing rat brain at the neurogenesis stage. Injury was induced in rat fetuses by transplacental administration of ethylnitrosourea (ENU) on embryonic Day (E) 16, and histological changes were examined up to 48 hr thereafter (i.e., up to E 18). In normal rat fetuses, MK immunostaining was observed in the cytoplasm and radial and horizontal processes of all cells in the neuroepithelium (NE), subventricular zone (SV), and intermediate zone (IMZ). In ENU-administered brains, cells in the NE, SV, and IMZ were damaged severely, especially 16-24 hr after ENU administration. The remaining neuroepithelial cells, with the exception of those in M-phase and the tips of processes at the ventricular surface, were negative for MK immunohistochemistry 16-24 hr after the administration of ENU. Forty-eight hours after the administration, the cytoplasm and processes of cells in the NE, SV, and IMZ were MK immunopositive. Our previous data reported that the cell cycle of most NE cells is synchronized to the S-phase 16 hr after ENU administration and to the M-phase at 24 hr, and many NE cells were recovered 48 hr after ENU administration. The previous results taken together with the present results indicate that: (1) MK expression does not increase during the repair period of the NE, being different from adults; (2) MK expression is likely to be suppressed at S-phase according to the condition of the NE; and (3) MK expression is not essential for every cell cycle phase of NE cells; but (4) is necessary to maintain the M-phase of NE cells.


Subject(s)
Brain Diseases/pathology , Carrier Proteins/metabolism , Cell Cycle/physiology , Neocortex/embryology , Neurons/metabolism , Alkylating Agents , Animals , Brain Diseases/chemically induced , Carrier Proteins/genetics , Cell Division/drug effects , Cytokines/genetics , Cytokines/metabolism , Ethylnitrosourea , Female , Gene Expression Regulation, Developmental , Immunohistochemistry , Male , Midkine , Neocortex/metabolism , Neocortex/ultrastructure , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Nerve Regeneration/genetics , Nerve Regeneration/physiology , Neurons/pathology , Neurons/ultrastructure , Organogenesis , Pregnancy , Rats
4.
Neuroreport ; 14(16): 2067-71, 2003 Nov 14.
Article in English | MEDLINE | ID: mdl-14600499

ABSTRACT

Intraocular injections of ciliary neurotrophic factor (CNTF) or intraocular adenovirus-mediated CNTF gene transfer have been reported to inhibit retinal alterations in inherited retinal degeneration in mice strains. To investigate whether or not CNTF administered by eye drops prevents retinal degeneration in streptozotocin (STZ)-induced diabetic rats, recombinant CNTF was administered to eyes of diabetic rats (n=20) twice daily for 1 month after the onset of diabetes. The b-wave amplitude of electroretinogram in CNTF-administered diabetic rats was significantly larger than that of diabetic rats, and approached that of the controls. Atrophy of the inner plexiform layer, and cavity formation in the pigment epithelium, which were observed in diabetic rats, were prevented in CNTF-administered diabetic rats. These results indicate that CNTF administration by eye drops prevents retinal degeneration in STZ-induced diabetic rats.


Subject(s)
Ciliary Neurotrophic Factor/therapeutic use , Diabetes Mellitus, Experimental/complications , Nerve Degeneration/prevention & control , Retinal Degeneration/prevention & control , Animals , Atrophy/drug therapy , Atrophy/physiopathology , Atrophy/prevention & control , Blood Glucose , Cell Death/drug effects , Cell Death/physiology , Ciliary Neurotrophic Factor/administration & dosage , Diabetes Mellitus, Experimental/chemically induced , Electroretinography/drug effects , Instillation, Drug , Male , Nerve Degeneration/etiology , Nerve Degeneration/physiopathology , Neurons/drug effects , Neurons/pathology , Pigment Epithelium of Eye/drug effects , Pigment Epithelium of Eye/pathology , Pigment Epithelium of Eye/physiopathology , Rats , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Retinal Degeneration/etiology , Retinal Degeneration/physiopathology , Treatment Outcome
5.
Neuropathology ; 22(3): 161-70, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12416555

ABSTRACT

Early pathological and electro-physiological changes of the retina in the streptozotocin (STZ)-diabetic rats were investigated through optical and electron microscopy in two strains and electro-retinography in one strain. In Sprague-Dawley (SD) rats I month after the onset of diabetes, the thickness of the inner plexiform layer (IPL) and photoreceptor segment layer (PSL) was significantly reduced by 9.9% and 18.9%, respectively (P < 0.01, P < 0.05). In Brown-Norway (BN) rats STZ-diabetic for 1 month, the thickness of the IPL was also significantly reduced by 15.7% (P < 0.05). Cytochemical study using peanut agglutinin (PNA), a lectin binding selectively to the cone photoreceptor-associated domains of the inter-photoreceptor matrix, revealed a marked reduction in intensity, number and length of the PNA-binding cone photoreceptors. Electron microscopy showed deepened hollows in the basal infoldings of the retinal pigment epithelium (RPE) of STZ-rats diabetic for 1 month and large concavities into the cytoplasm in STZ-rats diabetic for 6 months. Blood vessels in the retina and choroid were unremarkable. Single-flash electro-retinogram revealed a reduction in the amplitudes of alpha- and beta-waves of electro-retinogram (ERG) of 1 month STZ BN rats (P < 0.05). These findings indicate that the degeneration of rods/cones in the PSL and RPE are the most prominent pathological alteration sites in the early stage of diabetic rats.


Subject(s)
Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Experimental/physiopathology , Nerve Degeneration/pathology , Retina/physiopathology , Retina/ultrastructure , Animals , Choroid/metabolism , Choroid/pathology , Choroid/physiopathology , Diabetes Mellitus, Experimental/metabolism , Electroretinography , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry , Male , Microscopy, Electron , Peanut Agglutinin/metabolism , Pigment Epithelium of Eye/metabolism , Pigment Epithelium of Eye/pathology , Pigment Epithelium of Eye/physiopathology , Rats , Rats, Sprague-Dawley , Retina/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...